Su et al. (2019) investigated the use of anti-CD44 antibody-conjugated superparamagnetic iron oxide nanoparticles to target CD44, a well-characterized oral carcinoma biomarker that facilitates cancer cell immune evasion. The gene discussed is CD44; the disease is cancer.